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Until 2004, identification of Nipah virus (NV)-like out-
breaks in Bangladesh was based on serology. We describe
the genetic characterization of a new strain of NV isolated
during outbreaks in Bangladesh (NV-B) in 2004, which con-
firms that NV was the etiologic agent responsible for these
outbreaks.
N
ipah virus (NV) and Hendra virus (HV), the only
members of the genus Henipavirus within the family
Paramyxoviridae are different from most other paramyx-
oviruses because they have a broad host range in vivo and
in vitro. Although HV and NV have genetic characteristics
and replication strategies similar to those of other
paramyxoviruses, the henipaviruses have several unique
genetic features (1,2–4). 
The first outbreak of NV occurred between late 1998
and early 1999 in peninsular Malaysia and Singapore and
was associated with respiratory disease in swine and acute
and febrile encephalitis in humans. Direct contact with
sick pigs was the primary source of human infection (1).
Of 265 human cases, 108 were fatal. Although NV is
excreted in respiratory secretions and urine of patients
(1,5), a survey of healthcare workers in Malaysia showed
no evidence of human-to-human transmission (6). The
reservoir of NV is presumed to be fruit bats, primarily of
the genus Pteropus (7,8), and humans are infected through
intermediate hosts such as pigs. 
Recently, NV has been established as the cause of fatal,
febrile encephalitis in human patients in Bangladesh dur-
ing the winters of 2001, 2003, and 2004 (9–12). An NV-
like virus was identified as the cause of the outbreaks in
2001 and 2003 on the basis of serologic testing (12). Two
outbreaks consisting of 48 cases of NV were detected in
2004 in 2 adjacent districts (30 km apart) of central
Bangladesh (Rajbari and Faridpur) with a case-fatality rate
of nearly 75%. Because of heightened surveillance, other
small clusters and isolated cases (n = 19) were identified
during the same period in 7 other districts in central and
northwest Bangladesh. Although antibodies to NV were
detected in fruit bats from the affected areas in 2004, an
intermediate animal host was not identified, which sug-
gests that the virus was transmitted from bats to humans.
Human-to-human transmission of NV was also document-
ed during the Faridpur outbreak (10,11). We describe the
genetic characteristics of 4 NV isolates from the outbreak
in Bangladesh in 2004.
The Study
Virus isolation was performed in the BSL-4 laboratory at
the Centers for Disease Control and Prevention in Atlanta.
Vero E6 cells were inoculated and observed for characteris-
tic cytopathic effect, syncytium formation (1,5). NV was
isolated from 2 oropharyngeal swabs (SPB200401066,
SPB200406506), 1 cerebrospinal fluid (SPB200401617),
and 1 urine specimen (SPB200405758) from human
patients, and isolation was confirmed by reverse transcrip-
tion polymerase chain reaction (RT-PCR). Two isolates
were from Rajbari, and 1 was from Faridpur; the fourth iso-
late, from the Rajshahi district (100 km from Rajbari), was
not linked to the other 2 outbreaks. The complete genomic
sequence of the first viral isolate (SPB200401066) from
Rajbari was derived and submitted to GenBank (accession
no. AY988601) as NV-Bangladesh (NV-B). The sequences
of the open reading frame (ORF) coding for nucleoprotein
(N) were obtained for the other 3 isolates. The methods used
for RT-PCR, sequencing, cDNA cloning, rapid amplifica-
tion of cDNA ends (RACE), and sequence analysis were
previously described (2,3).
The genome of NV-B is 18,252 nt in length, 6 nt longer
than NV-Malaysia (NV-M), the prototype strain of NV
(SPB199901924). The additional 6 nt map to the 5′ non-
translated region of the fusion protein (F) gene. The length
of the NV-B genome is evenly divisible by 6, suggesting
that NV-B follows the “rule of six” (3). The gene order and
sizes of all the ORFs except V are conserved between NV-
B and NV-M (Table, Figure, A). The overall nucleotide
homology between the genomes of NV-B and NV-M is
91.8%, but the changes are not uniformly distributed
throughout the genome. Nucleotide homologies are higher
in the protein coding regions than in the noncoding
regions, although the sizes of the nontranslated regions
remain highly conserved (Table). The predicted amino acid
homologies between the proteins expressed by NV-M and
NV-B are all >92% (Table).
Overall, the predicted amino acid homologies of the
surface glycoproteins, F and G, of NV-B and NV-M are
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Dhaka, Bangladeshhigh (Table). In the F protein, the predicted cleavage site,
F1 amino-terminal domain, transmembrane domain, and
predicted N-glycosylation sites are identical in NV-B and
NV-M (2). Four of the 9 predicted amino acid changes
occur in the first 11 amino acids (aa) of the precursor of the
F protein, F0, which fall within the predicted signal pep-
tide and would be cleaved from the mature protein. Within
the G proteins, the predicted transmembrane domains, and
the positions of all 17 cysteine residues are conserved
between NV-B and NV-M. Of 8 predicted N-linked glyco-
sylation sites in the G protein of NV-M, 6 are conserved in
NV-B and in HV (2). 
The coding strategy of the P gene is identical in NV-B
and NV-M. In these viruses, the P gene contains the C, V,
and W ORFs in addition to the P ORF. Like most other
paramyxoviruses, the henipaviruses have a conserved AG-
rich region that acts as an editing site to facilitate the addi-
tion of nontemplated G residues into the transcripts of the
P gene. The edited transcripts encode 2 proteins, V and W,
which are co-amino-terminal with P but have unique car-
boxy termini (2). The addition of 1 G residue generates the
mRNA for the V protein, and the addition of 2 G residues
produces the mRNA for the W protein. Sequence analysis
of multiple cDNAclones containing the editing site of NV-
B identified edited transcripts that encoded both the V and
W proteins (data not shown). The conserved 20-nt region
encompassing the editing site is identical in NV-M, HV,
and measles virus (MV) (2); however, the editing of site of
NV-M (UGGGUAAUUUUUCCCGUGUC) differs from
NV-B (GGGAUAAUUUUUCCCGUGUC) at 2 nt posi-
tions (underlined). The functional significance of these 2
substitutions is under investigation. All of the cysteine
residues are conserved in the V proteins of NV-B and NV-
M; however, the unique portion of the V protein of NV-B
is predicted to be 55 aa, 3 aa longer than the V protein of
NV-M. The predicted W protein of NV-B is identical in
size and sequence to the W protein of NV-M. Recently, aa
100–160 and 230–237 of the V protein of NV-M have been
identified as necessary for inhibition of interferon signal-
ing (14). These regions are highly conserved in the V pro-
tein of NV-B, which has 4 predicted amino acids
substitutions (1 conservative) between positions 100–160
and no predicted substitutions between positions 230–237.
In addition, the V protein of NV-B has 3 predicted amino
acid substitutions in the CRM1-dependent nuclear export
signal that was identified between aa 174–193 in the V
protein of NV-M (14). The biologic effects of these amino
acid substitutions are under investigation.
The L proteins of NV-B and NV-M had a high level of
predicted amino acid conservation (Table). The 6 highly
conserved domains of viral polymerases, originally
described by Poch et al. (15) and delineated for NV-M by
Harcourt et al (3), remain largely unchanged between NV-B
and NV-M. Domains 1, 2, and 5 have 1 conservative amino
acid change each and domain 3, which is considered the
most conserved domain within the L proteins of paramyx-
oviruses, has 2 aa changes. The 4 motifs identified in
domain 3, including the QGDNE motif, which is assumed
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the NV-B and NV-M, as is the predicted nucleotide-bind-
ing motif in domain 6. 
The cis-acting control sequences are highly conserved
in the genomes of NV-B and NV-M. As in NV-M, the inter-
genic sequences in NV-B are GAA, with the exception of
the sequence between the G and L genes, UAA, which is
unique among the henipaviruses. However, the intergenic
sequence between the G and L genes is GAAin the second
isolate from Bangladesh. The transcriptional start and stop
signals of each gene of NV-B are highly conserved in rela-
tion to the other henipaviruses. The 3′ leader sequence of
NV-B is identical in length to those of all other paramyx-
oviruses and has nucleotide changes at positions 14 and 47
compared to NV-M. The 5′ trailer of NV-B is identical in
length and sequence to NV-M.
Phylogenetic analysis was used to compare the
sequence of the N ORF of NV-B to the sequences of the N
ORFs from other members of the subfamily Paramyxo-
virinae. The results confirmed the results of the sequence
comparisons, which show that NV-B is most closely relat-
ed to the henipavirus NV-M, and support the conclusion
that NV-B should be regarded as new strain of NV (Figure,
B). Phylogenetic analyses conducted with the sequences of
the other genes produced similar results (data not shown).
The sequences of the N ORFs of 4 NV isolates from
Bangladesh share 99.1% nt homology (Figure, C) but
exhibited more interstrain nucleotide heterogeneity than
the sequences of the human isolates in Malaysia, which
were nearly identical (1,8,13). These varying amounts of
genetic variability may reflect differences in the mode of
transmission of NV in the 2 countries. In Malaysia, molec-
ular evidence suggests that at least 2 introductions of NV
into pigs occurred (Figure, C). However, the nearly identi-
cal sequences of human and pig isolates from the later
phase of the outbreak suggest that only 1 of the variants
spread rapidly in pigs and was associated with most human
cases (13). In contrast, the sequence heterogeneity
observed in Bangladesh may be the result of multiple
introductions of NV into humans from different colonies
of fruit bats.
Conclusions
This first look at strain variation in NV indicates that
viruses circulating in different areas have unique genetic
signatures and suggests that these strains may have coe-
volved within the local natural reservoirs. Until 2004,
identification of NV outbreaks in Bangladesh had been
based only on serologic testing. The isolation and genetic
characterization of NV-B confirm that NV was the etiolog-
ic agent responsible for these outbreaks. 
Note: After this article was accepted for publication,
Nipah virus was isolated from Pteropus lylei in Cambodia
(16). Phylogenetic analysis of the N gene sequences
demonstrated that this virus is more closely related to
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Figure. A) Schematic representation of the genome of Nipah virus
(NV). Negative-sense genomic RNA is shown in 3′ to 5′ orienta-
tion. Open reading frames (ORFs) are indicated by shaded boxes:
N, nucleoprotein; P, phosphoprotein; M, matrix protein; F, fusion
protein; G, attachment protein; L, polymerase protein. B)
Phylogenetic analysis of the N ORFs from members of the sub-
family  Paramyxovirinae. Arrows identify the 5 genera. A
phenogram of the N ORFs of members of this subfamily was cre-
ated by using maximum parsimony analysis with PAUP 4.02
(Sinauer Associates, Sunderland, MA, USA). Abbreviations and
accession numbers: HPIV-1, human parainfluenza virus, D01070;
Sendai, X00087; HPIV-3, D10025; CDV, canine distemper virus,
AF014953; PDV, phocine distemper virus, X75717; RPV,
Rinderpest virus, X68311; MV, K01711; DMV, dolphin Morbillivirus,
X75961; NDV, Newcastle disease virus, AF064091; GP, goose
paramyxovirus, AF473851; HPIV-4b, M32983; HPIV-4a, M32982;
Tioman, AF298895; Menangle, AF326114; HPIV-2, M55320;
Simian virus 5 (SV5), M81442; Mumps, D86172; NV-UMCC1,
AY029767; NV-Malaysia, AF212302; NV-P. hypomelanus,*
AF376747; NV-Bangladesh; Hendra virus, AF017149; Tupaia
paramyxovirus, AF079780; Mossman virus, AY286409; and Salem
virus, AF237881. C) The phylogenetic relationship between the N
gene sequences of the 4 human NV isolates from the Bangladesh
outbreak in 2004 and the N gene sequences from pig and human
NV isolates from Malaysia. Accession numbers for the pig isolates
of NV (13) are AJ627196, AJ564622, and AJ564621. *NV-P.
hypomelanus is sequence from a virus isolated from Pteropus
hypomelanus, the Island Flying Fox (8).Nipah-Malaysia than to Nipah-Bangladesh and represented
another lineage of Nipah virus.
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